IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19,983,105 | -61.4% | 2,491,659 | -28.7% | 0.07% | -60.8% |
| Q1 2024 | $51,783,807 | +547.9% | 3,494,184 | +255.4% | 0.19% | +509.7% |
| Q4 2023 | $7,992,440 | +776.4% | 983,080 | +390.5% | 0.03% | +675.0% |
| Q3 2023 | $911,929 | -75.6% | 200,424 | -62.2% | 0.00% | -77.8% |
| Q2 2023 | $3,732,200 | -45.9% | 530,142 | -53.0% | 0.02% | -47.1% |
| Q1 2023 | $6,897,658 | -36.9% | 1,128,913 | -34.0% | 0.03% | -44.3% |
| Q4 2022 | $10,932,280 | -20.9% | 1,710,842 | +18.6% | 0.06% | -18.7% |
| Q3 2022 | $13,824,000 | +24.6% | 1,443,048 | +43.6% | 0.08% | +31.6% |
| Q2 2022 | $11,096,000 | -10.6% | 1,005,107 | +34.9% | 0.06% | -18.6% |
| Q1 2022 | $12,408,000 | +7.7% | 745,212 | +23.4% | 0.07% | +11.1% |
| Q4 2021 | $11,524,000 | -26.8% | 603,676 | -5.4% | 0.06% | -37.6% |
| Q3 2021 | $15,744,000 | -12.8% | 638,434 | -8.0% | 0.10% | -19.2% |
| Q2 2021 | $18,048,000 | +577.7% | 693,617 | +724.6% | 0.12% | +557.9% |
| Q1 2021 | $2,663,000 | +58.0% | 84,111 | +131.6% | 0.02% | +35.7% |
| Q4 2020 | $1,685,000 | – | 36,311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |